According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), Elevance Health has once again reaffirmed its performance outlook for fiscal year 2026, expecting adjusted shareholder earnings to remain at no less than $25.50 per diluted share.

According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), Elevance Health has once again reaffirmed its performance outlook for fiscal year 2026, expecting adjusted shareholder earnings to remain at no less than $25.50 per diluted share.

老虎证券2026/03/10 10:41

Show original

This statement reinforces the company's confidence in its medium- and long-term financial goals, reflecting management's ongoing control over operational efficiency and growth paths in a complex market environment. Investors can use this to assess the strategic determination and profit resilience of this healthcare giant amid industry transformation.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops

Lock your assets and earn 10%+ APR

Lock now!

According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), Elevance Health has once again reaffirmed its performance outlook for fiscal year 2026, expecting adjusted shareholder earnings to remain at no less than $25.50 per diluted share.

You may also like

Trending news

Crypto prices